A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
Clinical trial NCT07344779 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07344779
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-29
- Primary completion
- 2029-12-31
- Enrollment
- 1600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.